In men, however, tests for prostate-specific antigen (PSA), serum chorionic gonadotropin (β-hCG), and alpha-fetoprotein (AFP) are recommended, to rule out treatable extragonadal germ cell tumours or prostate cancer eligible for endocrine therapy. The gene discussed is KLK3; the disease is germ cell tumor.